Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (141-150 of 584) with videos related to

Pageof 59
Sort By:
Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.
Leukemia & Lymphoma|December 30, 2009
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosisSameer A Parikh, Hagop M Kantarjian, Mary Ann Richie, et al.
International Journal of Laboratory Hematology|June 19, 2015
Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasmZ Chen, W Wang, S Verstovsek, et al.
Parasitology|February 20, 2007
In vitro efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besnoitia besnoiti infection in Vero cellsH C E Cortes, N Mueller, M Esposito, et al.
Journal of Surgical Oncology|April 1, 1996
Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II studyD Nori, O Merimsky, A D Osian, et al.
American Journal of Hematology|September 9, 2015
The impact of dasatinib on pregnancy outcomesJorge E Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Troxacitabine activity in extramedullary myeloid leukemiaYesid Alvarado, Hagop M Kantarjian, Jorge E Cortes, et al.
Journal of Hematology & Oncology|October 27, 2022
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trialJorge E Cortes, Tara L Lin, Kobby Asubonteng, et al.
Annals of Internal Medicine|April 15, 1990
Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infectionsS A Miles, H J Wang, E Cortes, et al.
The Journal of General Virology|September 1, 1993
Topographical analysis of canine parvovirus virions and recombinant VP2 capsidsE Cortes, C San Martin, J Langeveld, et al.
Pageof 59

Showing results (141-150 of 584) with videos related to

Sort By:
Pageof 59
Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.
Leukemia & Lymphoma|December 30, 2009
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosisSameer A Parikh, Hagop M Kantarjian, Mary Ann Richie, et al.
International Journal of Laboratory Hematology|June 19, 2015
Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasmZ Chen, W Wang, S Verstovsek, et al.
Parasitology|February 20, 2007
In vitro efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besnoitia besnoiti infection in Vero cellsH C E Cortes, N Mueller, M Esposito, et al.
Journal of Surgical Oncology|April 1, 1996
Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II studyD Nori, O Merimsky, A D Osian, et al.
American Journal of Hematology|September 9, 2015
The impact of dasatinib on pregnancy outcomesJorge E Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Troxacitabine activity in extramedullary myeloid leukemiaYesid Alvarado, Hagop M Kantarjian, Jorge E Cortes, et al.
Journal of Hematology & Oncology|October 27, 2022
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trialJorge E Cortes, Tara L Lin, Kobby Asubonteng, et al.
Annals of Internal Medicine|April 15, 1990
Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infectionsS A Miles, H J Wang, E Cortes, et al.
The Journal of General Virology|September 1, 1993
Topographical analysis of canine parvovirus virions and recombinant VP2 capsidsE Cortes, C San Martin, J Langeveld, et al.
Pageof 59